Biodiffusion chambers containing irradiated glioma cells, prepared from excised tumor tissues, and an immunostimulatory IGF-1R antisense selectively produce glioma antigens in an immunogenic format appropriate for vaccination. This evidence concerns the gene IGF1R and neoplasm.